Stanley-Laman Group, Ltd. - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 165 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q1 2016$519,000
-84.3%
3,625
-83.1%
0.10%
-82.7%
Q4 2015$3,315,000
+10.1%
21,447
+1.7%
0.57%
-7.3%
Q3 2015$3,012,000
-9.6%
21,080
-9.1%
0.61%
+0.5%
Q2 2015$3,331,00023,1800.61%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2016
NameSharesValueWeighting ↓
HealthInvest Partners AB 85,205$9,416,0007.01%
FORT, L.P. 149,014$16,468,0005.67%
Strategic Global Advisors, LLC 80,231$11,336,0004.23%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 701,900$77,567,0003.19%
Ativo Capital Management LLC 78,727$8,700,0002.01%
Analyst IMS Investment Management Services Ltd. 31,438$3,474,0001.47%
Parametrica Management Ltd 4,327$478,0001.32%
Freestone Capital Holdings, LLC 89,005$9,836,0000.90%
RPG Investment Advisory, LLC 19,580$2,163,0000.68%
MERITAGE PORTFOLIO MANAGEMENT 38,465$4,251,0000.47%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders